Viewing Study NCT00658892


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2026-03-13 @ 12:15 PM
Study NCT ID: NCT00658892
Status: COMPLETED
Last Update Posted: 2017-05-25
First Post: 2008-04-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma (Skin) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent melanoma View
None stage IV melanoma View